Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice
- PMID: 6970211
Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice
Abstract
Experiments were performed to serve as a basis for analyzing the immune responses of the host to a viral respiratory tract infection. In a comparative study, inbred BALB/c and nude (athymic mice bred on a BALB/c background) mice were infected intranasally with mouse adapted A/Port Chalmers/1/73 influenza virus. Survival was prolonged in the nude mice (16 days vs 10 days for BALB/c mice, t = 3.5, p less than 0.01), but significantly fewer of the nude mice survived 21 days (16% vs 42% of BALB/c mice). In addition, virus persisted longer in the lungs of nude mice (5.8 log10 of infectious virus on day 21 vs no detectable virus in BALB/c mice) and lung pathology progressed more slowly but lasted longer in nude mice, as measured by immunofluorescent and histologic examination of pulmonary tissue. Antibody production was significantly lower and there was no cytotoxic T cell response detected in lymphoid cells prepared from the spleens, peripheral blood, or the lung after the infection of nude mice. A significant increase in the number of lymphocytes isolated from the lung was observed by day 7 (t = 5.8, p less than 0.001) in the BALB/c mice but not until day 14 (t = 4.9, p less than 0.001) in the nude mice. Lymphocytes from nude mice did not respond to influenza virus antigens or Concanavalin A (Con A) but did respond to lipopolysaccharide (LPS), whereas lymphocytes from BALB/c mice responded to all 3 preparations.
Similar articles
-
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.J Immunol. 1992 Jan 1;148(1):212-7. J Immunol. 1992. PMID: 1530795
-
Pulmonary immune response of young and aged mice after influenza challenge.J Lab Clin Med. 1995 Aug;126(2):169-77. J Lab Clin Med. 1995. PMID: 7636390
-
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia.J Immunol. 1981 Mar;126(3):1042-6. J Immunol. 1981. PMID: 7462625 No abstract available.
-
Defense mechanisms against influenza virus infection in the respiratory tract mucosa.Jpn J Infect Dis. 2004 Dec;57(6):236-47. Jpn J Infect Dis. 2004. PMID: 15623947 Review.
-
Immune responses to influenza virus in the mouse, and their role in control of the infection.Br Med Bull. 1979 Jan;35(1):65-8. doi: 10.1093/oxfordjournals.bmb.a071544. Br Med Bull. 1979. PMID: 367489 Review. No abstract available.
Cited by
-
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.PLoS Pathog. 2006 Jun;2(6):e53. doi: 10.1371/journal.ppat.0020053. Epub 2006 Jun 9. PLoS Pathog. 2006. PMID: 16789835 Free PMC article.
-
CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms.Eur J Immunol. 2007 May;37(5):1266-74. doi: 10.1002/eji.200636755. Eur J Immunol. 2007. PMID: 17429844 Free PMC article.
-
Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.Viruses. 2018 Aug 10;10(8):420. doi: 10.3390/v10080420. Viruses. 2018. PMID: 30103427 Free PMC article.
-
Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.PLoS Pathog. 2019 Sep 16;15(9):e1008036. doi: 10.1371/journal.ppat.1008036. eCollection 2019 Sep. PLoS Pathog. 2019. PMID: 31525249 Free PMC article.
-
CD8 T Cell Vaccines and a Cytomegalovirus-Based Vector Approach.Life (Basel). 2021 Oct 15;11(10):1097. doi: 10.3390/life11101097. Life (Basel). 2021. PMID: 34685468 Free PMC article. Review.